See the DrugPatentWatch profile for polivy
Understanding the Age Range for Polivy's Clinical Trial Participants
Introduction
Polivy, also known as polatuzumab vedotin, is a monoclonal antibody-drug conjugate (ADC) used in the treatment of certain types of non-Hodgkin lymphoma (NHL). Developed by Genentech, a member of the Roche Group, Polivy has shown promising results in clinical trials, particularly in patients with diffuse large B-cell lymphoma (DLBCL). However, to ensure the efficacy and safety of this medication, clinical trials involving Polivy have specific inclusion and exclusion criteria, including age ranges for participants.
What is the Age Range for Polivy's Clinical Trial Participants?
According to the clinical trial data available on DrugPatentWatch.com, a reliable source for pharmaceutical patent and clinical trial information, the age range for Polivy's clinical trial participants varies depending on the specific trial. However, most trials have included participants between the ages of 18 and 75 years old. For example, a Phase II clinical trial (NCT02013154) for Polivy in combination with bendamustine and rituximab in patients with DLBCL had an age range of 18 to 75 years old.
Why is Age a Critical Factor in Clinical Trials?
Age is a critical factor in clinical trials because it can affect the pharmacokinetics and pharmacodynamics of medications. Older adults may have altered drug metabolism, reduced renal function, and increased comorbidities, which can impact the efficacy and safety of treatments. In the case of Polivy, the age range for clinical trial participants is likely chosen to ensure that the medication is tested in a population that is representative of the target patient population.
What are the Inclusion and Exclusion Criteria for Polivy's Clinical Trials?
In addition to age, clinical trials for Polivy have other inclusion and exclusion criteria, such as:
* Diagnosis of DLBCL or other types of NHL
* ECOG performance status of 0-2
* Adequate organ function
* No prior treatment with Polivy or other ADCs
* No active malignancy other than NHL
What are the Benefits of Including Older Adults in Clinical Trials?
Including older adults in clinical trials can provide valuable insights into the safety and efficacy of medications in this population. Older adults are more likely to experience comorbidities and polypharmacy, which can impact treatment outcomes. By including older adults in clinical trials, researchers can better understand how to tailor treatments to meet the unique needs of this population.
What are the Challenges of Conducting Clinical Trials in Older Adults?
Conducting clinical trials in older adults can be challenging due to factors such as:
* Reduced physical function and mobility
* Increased comorbidities and polypharmacy
* Cognitive impairment
* Social and economic factors that impact access to care
Conclusion
In conclusion, the age range for Polivy's clinical trial participants is typically between 18 and 75 years old. However, the specific inclusion and exclusion criteria for each trial may vary. By including older adults in clinical trials, researchers can better understand how to tailor treatments to meet the unique needs of this population.
Key Takeaways
* The age range for Polivy's clinical trial participants is typically between 18 and 75 years old.
* Age is a critical factor in clinical trials due to altered drug metabolism and increased comorbidities in older adults.
* Including older adults in clinical trials can provide valuable insights into the safety and efficacy of medications in this population.
* Conducting clinical trials in older adults can be challenging due to factors such as reduced physical function and mobility, increased comorbidities and polypharmacy, and cognitive impairment.
FAQs
1. Q: What is the age range for Polivy's clinical trial participants?
A: The age range for Polivy's clinical trial participants is typically between 18 and 75 years old.
2. Q: Why is age a critical factor in clinical trials?
A: Age is a critical factor in clinical trials because it can affect the pharmacokinetics and pharmacodynamics of medications.
3. Q: What are the benefits of including older adults in clinical trials?
A: Including older adults in clinical trials can provide valuable insights into the safety and efficacy of medications in this population.
4. Q: What are the challenges of conducting clinical trials in older adults?
A: Conducting clinical trials in older adults can be challenging due to factors such as reduced physical function and mobility, increased comorbidities and polypharmacy, and cognitive impairment.
5. Q: Can older adults participate in clinical trials for Polivy?
A: Yes, older adults can participate in clinical trials for Polivy, but they must meet the specific inclusion and exclusion criteria for each trial.
Cited Sources
1. DrugPatentWatch.com. (2022). Polivy (polatuzumab vedotin) - Clinical Trials.
2. Genentech. (2022). Polivy (polatuzumab vedotin) - Prescribing Information.
3. National Cancer Institute. (2022). Non-Hodgkin Lymphoma Treatment (PDQ).
4. American Society of Clinical Oncology. (2022). Non-Hodgkin Lymphoma Treatment.
5. European Medicines Agency. (2022). Polivy (polatuzumab vedotin) - Summary of Product Characteristics.